Trastuzumab Unknown Status Phase 3 Trials for Cancer, Breast Treatment

IndicationsStatusPurposePhase
Unknown StatusTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00712140Trastuzumab in Treating Women With HER2-Positive Early Breast Cancer
NCT00045032Trastuzumab in Treating Women With Primary Breast Cancer
NCT00629278Combination Chemotherapy and Trastuzumab in Treating Women With Stage I, Stage II, or Stage III HER2-Positive Breast Cancer
NCT00430001Vinorelbine Plus (+) Trastuzumab vs Docetaxel Plus (+) Trastuzumab as 1 Line Treatment for HER2 Positive (+) Metastatic Breast Cancer